Pre-made Emactuzumab biosimilar ( Whole mAb, anti-CSF1R therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-174
Anti-CSF1R therapeutic antibody (Pre-made Emactuzumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Emactuzumab (RG-7155) is a humanized monoclonal antibody directed against CSF-1R expressed on macrophages[ and has demonstrated a profound antitumor effect through interference with the CSF-1/CSF-1R axis, along with a manageable safety profile in patients with diffuse-type tenosynovial giant cell tumors (d-TGCT)
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-CSF1R therapeutic antibody (Pre-made Emactuzumab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Phase-II|
|100% SI Structure||4liq:HL|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Roche;University of Texas M. D. Anderson Cancer Center|
|Conditions Active||Fallopian tube cancer;Ovarian cancer;Peritoneal cancer;Solid tumours|
|Conditions Discontinued||Giant cell tumour of tendon sheath;Pigmented villonodular synovitis|